Buyer Name: NHS England
Buyer Address: Wellington House, 133-135 Waterloo Rd, London, UKI45, SE1 8UG, United Kingdom
Contact Email: katie.noonan@nhs.net
NHS National Framework for Golimumab Injection
Buyer Contact Info
Status
complete
complete
Procedure
open
open
Value
60000000.0 GBP
60000000.0 GBP
Published
17 Oct 2025, 16:40
17 Oct 2025, 16:40
Deadline
n/a
n/a
Contract Start
01 Nov 2025, 00:00
01 Nov 2025, 00:00
Contract End
31 Oct 2026, 23:59
31 Oct 2026, 23:59
Category
n/a
n/a
CPV
33600000 - Pharmaceutical products
33600000 - Pharmaceutical products
Region
n/a
n/a
Awarded To
Janssen Cilag Ltd, MERCURY PHARMACEUTICALS LIMITED, ORIFARM UK LTD
Janssen Cilag Ltd, MERCURY PHARMACEUTICALS LIMITED, ORIFARM UK LTD
Official Source
Open Find a Tender
Open Find a Tender
Description
NHS National Framework for Golimumab Injection commencing 1st November 2025 Offer reference number: CM/TNS/25/5724 Period of framework: 1 November 2025 to 31 October 2026 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 48 months. Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England
Linked Documents
Select a document to preview.
Opportunity Context
Lots
Lot 1 Status: complete
Documents
Document Description: Not published
Contracts
Contract Title: NHS National Framework for Golimumab Injection commencing 1st November 2025
Raw Notice JSON
Expand raw payload
{
"awards": [
{
"id": "2",
"items": [
{
"additionalClassifications": [
{
"description": "Pharmaceutical products",
"id": "33600000",
"scheme": "CPV"
}
],
"deliveryAddresses": [
{
"country": "GB",
"countryName": "United Kingdom",
"region": "UKC"
},
{
"country": "GB",
"countryName": "United Kingdom",
"region": "UKD"
},
{
"country": "GB",
"countryName": "United Kingdom",
"region": "UKF"
},
{
"country": "GB",
"countryName": "United Kingdom",
"region": "UKG"
},
{
"country": "GB",
"countryName": "United Kingdom",
"region": "UKH"
},
{
"country": "GB",
"countryName": "United Kingdom",
"region": "UKJ"
},
{
"country": "GB",
"countryName": "United Kingdom",
"region": "UKK"
}
],
"id": "1",
"relatedLot": "1"
}
],
"mainProcurementCategory": "goods",
"relatedLots": [
"1"
],
"status": "active",
"suppliers": [
{
"id": "GB-COH-01027904",
"name": "Janssen Cilag Ltd"
},
{
"id": "GB-COH-02619880",
"name": "MERCURY PHARMACEUTICALS LIMITED"
},
{
"id": "GB-COH-10015046",
"name": "ORIFARM UK LTD"
}
]
}
],
"buyer": {
"id": "GB-PPON-PDPT-3135-BWWY",
"name": "NHS England"
},
"contracts": [
{
"aboveThreshold": true,
"awardID": "2",
"dateSigned": "2025-09-23T00:00:00+01:00",
"documents": [
{
"description": "CONTRACT COPY - Docs - Contract Details Notice CM-TNS-25-5724",
"documentType": "contractSigned",
"format": "application/pdf",
"id": "A-6367",
"url": "https://www.find-tender.service.gov.uk/Notice/Attachment/A-6367"
},
{
"datePublished": "2025-10-17T17:40:23+01:00",
"description": "Contract details notice on Find a Tender",
"documentType": "contractNotice",
"format": "text/html",
"id": "066506-2025",
"noticeType": "UK7",
"url": "https://www.find-tender.service.gov.uk/Notice/066506-2025"
}
],
"hasRenewal": true,
"id": "2",
"period": {
"endDate": "2026-10-31T23:59:59Z",
"maxExtentDate": "2029-10-31T23:59:59Z",
"startDate": "2025-11-01T00:00:00Z"
},
"renewal": {
"description": "option or options to extend (at the discretion of the Authority) up to maximum of 24 months."
},
"status": "active",
"title": "NHS National Framework for Golimumab Injection commencing 1st November 2025",
"value": {
"amount": 60000000.0,
"amountGross": 72000000.0,
"currency": "GBP"
}
}
],
"date": "2025-10-17T17:40:23+01:00",
"id": "066506-2025",
"initiationType": "tender",
"language": "en",
"ocid": "ocds-h6vhtk-052c77",
"parties": [
{
"address": {
"country": "GB",
"countryName": "United Kingdom",
"locality": "London",
"postalCode": "SE1 8UG",
"region": "UKI45",
"streetAddress": "Wellington House, 133-135 Waterloo Rd"
},
"contactPoint": {
"email": "katie.noonan@nhs.net"
},
"details": {
"classifications": [
{
"description": "Public authority - central government",
"id": "publicAuthorityCentralGovernment",
"scheme": "UK_CA_TYPE"
}
],
"url": "https://www.england.nhs.uk/"
},
"id": "GB-PPON-PDPT-3135-BWWY",
"identifier": {
"id": "PDPT-3135-BWWY",
"scheme": "GB-PPON"
},
"name": "NHS England",
"roles": [
"buyer"
]
},
{
"address": {
"country": "GB",
"countryName": "United Kingdom",
"locality": "High Wycombe",
"postalCode": "HP12 4EG",
"region": "UKJ13",
"streetAddress": "50-100 Holmers Farm Way"
},
"contactPoint": {
"email": "commercialjc@its.jnj.com"
},
"details": {
"publicServiceMissionOrganization": false,
"scale": "large",
"shelteredWorkshop": false,
"vcse": false
},
"id": "GB-COH-01027904",
"identifier": {
"id": "01027904",
"scheme": "GB-COH"
},
"name": "Janssen Cilag Ltd",
"roles": [
"supplier"
]
},
{
"address": {
"country": "GB",
"countryName": "United Kingdom",
"locality": "London",
"postalCode": "EC2M 1QS",
"region": "UKI31",
"streetAddress": "Dashwood House"
},
"contactPoint": {
"email": "commercialsupporthospitals@advanzpharma.com"
},
"details": {
"publicServiceMissionOrganization": false,
"scale": "large",
"shelteredWorkshop": false,
"vcse": false
},
"id": "GB-COH-02619880",
"identifier": {
"id": "02619880",
"scheme": "GB-COH"
},
"name": "MERCURY PHARMACEUTICALS LIMITED",
"roles": [
"supplier"
]
},
{
"address": {
"country": "GB",
"countryName": "United Kingdom",
"locality": "Hemel Hempstead",
"postalCode": "HP2 4TZ",
"region": "UKH23",
"streetAddress": "Ground Floor, Suite A2 Breakspear Way"
},
"contactPoint": {
"email": "uk_enquiries@orifarm.com"
},
"details": {
"publicServiceMissionOrganization": false,
"scale": "large",
"shelteredWorkshop": false,
"vcse": false
},
"id": "GB-COH-10015046",
"identifier": {
"id": "10015046",
"scheme": "GB-COH"
},
"name": "ORIFARM UK LTD",
"roles": [
"supplier"
]
}
],
"tag": [
"award",
"contract"
],
"tender": {
"coveredBy": [
"GPA"
],
"description": "NHS National Framework for Golimumab Injection commencing 1st November 2025\nOffer reference number: CM/TNS/25/5724\nPeriod of framework: 1 November 2025 to 31 October 2026 with an option or options to extend (at the Authority\u2019s discretion) for a period or periods up to a total of 48 months.\nPublished By: Medicines Procurement and Supply Chain - NHS Medicines Value \u0026 Access, NHS England",
"documents": [
{
"description": "Not published",
"documentType": "conflictOfInterest",
"id": "conflictOfInterest"
}
],
"id": "C366698",
"legalBasis": {
"id": "2023/54",
"scheme": "UKPGA",
"uri": "https://www.legislation.gov.uk/ukpga/2023/54/contents"
},
"lots": [
{
"id": "1",
"status": "complete"
}
],
"procurementMethod": "open",
"procurementMethodDetails": "Open procedure",
"status": "complete",
"techniques": {
"frameworkAgreement": {
"buyerCategories": "Please refer to Document No. 09 in the ITO Documents for the list of Purchasing Points",
"buyerLocationRestrictions": [
{
"gazetteer": {
"identifiers": [
"UKC"
],
"scheme": "GB-ITL"
}
},
{
"gazetteer": {
"identifiers": [
"UKD"
],
"scheme": "GB-ITL"
}
},
{
"gazetteer": {
"identifiers": [
"UKF"
],
"scheme": "GB-ITL"
}
},
{
"gazetteer": {
"identifiers": [
"UKG"
],
"scheme": "GB-ITL"
}
},
{
"gazetteer": {
"identifiers": [
"UKH"
],
"scheme": "GB-ITL"
}
},
{
"gazetteer": {
"identifiers": [
"UKJ"
],
"scheme": "GB-ITL"
}
},
{
"gazetteer": {
"identifiers": [
"UKK"
],
"scheme": "GB-ITL"
}
}
],
"description": "Please refer to the ITO Documents for the Operation Description",
"method": "withReopeningCompetition",
"type": "open"
},
"hasFrameworkAgreement": true
},
"title": "NHS National Framework for Golimumab Injection"
}
}